TD Asset Management
PRLD icon

TD Asset Management’s Prelude Therapeutics PRLD Stock Holding History

TD Asset Management’s Portfolio PRLD Stock Details PRLD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-160,652
Closed -$466K – 1284
2025
Q4 		$466K Hold
160,652
– – ﹤0.01% 1177
2025
Q3 		$231K Hold
160,652
– – ﹤0.01% 1213
2025
Q2 		$130K Hold
160,652
– – ﹤0.01% 1184
2025
Q1 		$123K Hold
160,652
– – ﹤0.01% 1203
2024
Q4 		$205K Hold
160,652
– – ﹤0.01% 1228
2024
Q3 		$341K Hold
160,652
– – ﹤0.01% 1334
2024
Q2 		$612K Hold
160,652
– – ﹤0.01% 1244
2024
Q1 		$761K Hold
160,652
– – ﹤0.01% 1226
2023
Q4 		$686K Hold
160,652
– – ﹤0.01% 1254
2023
Q3 		$496K Buy
160,652
+80,326
+100% +$301K ﹤0.01% 1284
2023
Q2 		$361K Buy
80,326
+51,886
+182% +$310K ﹤0.01% 1310
2023
Q1 		$162K Hold
28,440
– – ﹤0.01% 1388
2022
Q4 		$172K Hold
28,440
– – ﹤0.01% 1396
2022
Q3 		$185K Hold
28,440
– – ﹤0.01% 1407
2022
Q2 		$148K Hold
28,440
– – ﹤0.01% 1399
2022
Q1 		$196K Hold
28,440
– – ﹤0.01% 1431
2021
Q4 		$354K Hold
28,440
– – ﹤0.01% 1416
2021
Q3 		$889K Hold
28,440
– – ﹤0.01% 1280
2021
Q2 		$911K Hold
28,440
– – ﹤0.01% 1282
2021
Q1 		$1.23M Buy
28,440
+5,931
+26% +$393K ﹤0.01% 1225
2020
Q4 		$1.61M Hold
22,509
– – ﹤0.01% 1084
2020
Q3 		$678K Buy
+22,509
New +$636K ﹤0.01% 1172

Other funds holding PRLD

O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
KCM
Kynam Capital Management Princeton, New Jersey $1.62B AUM 138.67% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
EC
EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
SFM
Sphera Funds Management Tel Aviv, Israel $630M AUM 108.65% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return

TD Asset Management's PRLD Position: Q1 2026 in Review

TD Asset Management sold out of Prelude Therapeutics (PRLD) in Q1 2026, closing a stake of 160,652 shares — an estimated $466K sold.

TD Asset Management first reported a position in PRLD in Q3 2020 and held it in 22 quarters. The position peaked at $1.61M in Q4 2020. 55 funds tracked by Wall St. Rank hold PRLD as of Q1 2026.

  • TD Asset Management reported no remaining Prelude Therapeutics position as of Q1 2026 after selling out during the quarter.
  • TD Asset Management sold 160,652 Prelude Therapeutics shares in Q1 2026, an estimated $466K.
  • TD Asset Management first reported a position in Prelude Therapeutics in Q3 2020 and held it in 22 quarters.
  • TD Asset Management's Prelude Therapeutics position peaked at $1.61M in Q4 2020.
  • 55 funds tracked by Wall St. Rank held Prelude Therapeutics as of Q1 2026.

Based on TD Asset Management's 13F filing for Q1 2026, filed 11 May 2026.